Aleksandra K. Bruchey
Dr. Bruchey is an academically trained neuroscientist with over 25 years of expertise in development of biopharmaceuticals and devices in the areas of neurology, metabolic diseases, psychiatry, rare diseases, and endocrinology among others, with leadership roles in all facets of therapeutic candidate development from pre-clinical to Phase IV trials. Dr. Bruchey also has broad regulatory...Read More
Roy Smith
Dr. Roy Smith is Scientific Advisor, Endocrine Science of Lumos Pharma. He has more than fifty years of academic and industrial research experience focused on drug discovery with over 300 peer-reviewed publications and issued patents. Upon receiving his Ph.D. in organic chemistry from Queen Mary College, London University, UK., Roy crossed the pond to take...Read More
Dave Schrader
Dave Schrader is the Vice President, Quality and Compliance of Lumos Pharma. He brings twenty years of experience holding various quality and compliance roles throughout his career in the pharmaceutical industry. Prior to the merger with Lumos Pharma, he held various roles of increasing responsibility in the quality department at NewLink Genetics. As part of...Read More
Mark Bach
Dr. Bach is a pediatric endocrinologist with 30 years of clinical research and pharmaceutical development experience, including extensive global experience building and leading clinical teams that have successfully launched innovative pharmaceutical products into global markets. Dr. Bach is currently Chief Medical Officer at ShouTi. At his last position, Dr. Bach served as Senior Vice President...Read More
Peter Clayton
Dr. Clayton has been a Professor of Child Health and Paediatric Endocrinology at the University of Manchester since 2001. He has authored 200 publications on the clinical and basic science aspects of pediatric endocrinology and has served on the editorial boards of many endocrine journals ( Hormone Research in Paediatrics, European Journal of Endocrinology and...Read More